NO965165L - Anvendelse av 8,9-dehydroestron som en antioksydant - Google Patents

Anvendelse av 8,9-dehydroestron som en antioksydant

Info

Publication number
NO965165L
NO965165L NO965165A NO965165A NO965165L NO 965165 L NO965165 L NO 965165L NO 965165 A NO965165 A NO 965165A NO 965165 A NO965165 A NO 965165A NO 965165 L NO965165 L NO 965165L
Authority
NO
Norway
Prior art keywords
dehydroestrone
antioxidant
Prior art date
Application number
NO965165A
Other languages
English (en)
Other versions
NO312654B1 (no
NO965165D0 (no
Inventor
Steven Jay Adelman
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO965165D0 publication Critical patent/NO965165D0/no
Publication of NO965165L publication Critical patent/NO965165L/no
Publication of NO312654B1 publication Critical patent/NO312654B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19965165A 1995-12-04 1996-12-03 Anvendelse av 8,9-dehydroöstron NO312654B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US793195P 1995-12-04 1995-12-04

Publications (3)

Publication Number Publication Date
NO965165D0 NO965165D0 (no) 1996-12-03
NO965165L true NO965165L (no) 1997-06-05
NO312654B1 NO312654B1 (no) 2002-06-17

Family

ID=21728885

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965165A NO312654B1 (no) 1995-12-04 1996-12-03 Anvendelse av 8,9-dehydroöstron

Country Status (22)

Country Link
EP (1) EP0778025B1 (no)
JP (1) JPH09169650A (no)
KR (1) KR100444002B1 (no)
CN (1) CN1104900C (no)
AR (2) AR005866A1 (no)
AT (1) ATE263565T1 (no)
AU (1) AU703814B2 (no)
BR (1) BR9605777A (no)
CA (1) CA2191835A1 (no)
CZ (1) CZ289780B6 (no)
DE (1) DE69632117T2 (no)
DK (1) DK0778025T3 (no)
ES (1) ES2215187T3 (no)
HU (1) HUP9603329A3 (no)
IL (1) IL119744A (no)
MX (1) MX9606009A (no)
NO (1) NO312654B1 (no)
NZ (1) NZ299858A (no)
PT (1) PT778025E (no)
SI (1) SI0778025T1 (no)
SK (1) SK154296A3 (no)
ZA (1) ZA969923B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
JP2002322081A (ja) * 2001-02-22 2002-11-08 Nonogawa Shoji Kk 生体の遺伝子損傷抑制剤
US7892751B2 (en) 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
AU2004248155B2 (en) 2003-06-09 2008-10-23 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene

Also Published As

Publication number Publication date
AR059965A2 (es) 2008-05-14
EP0778025B1 (en) 2004-04-07
EP0778025A1 (en) 1997-06-11
HUP9603329A3 (en) 1998-01-28
HUP9603329A2 (en) 1997-08-28
AU7194496A (en) 1997-06-12
IL119744A0 (en) 1997-03-18
CA2191835A1 (en) 1997-06-05
AR005866A1 (es) 1999-07-21
DK0778025T3 (da) 2004-06-07
CN1158725A (zh) 1997-09-10
AU703814B2 (en) 1999-04-01
CN1104900C (zh) 2003-04-09
SI0778025T1 (en) 2004-08-31
NO312654B1 (no) 2002-06-17
NO965165D0 (no) 1996-12-03
PT778025E (pt) 2004-08-31
HK1010095A1 (en) 1999-06-11
DE69632117D1 (de) 2004-05-13
KR970032870A (ko) 1997-07-22
NZ299858A (en) 2001-03-30
KR100444002B1 (ko) 2004-11-03
CZ289780B6 (cs) 2002-04-17
DE69632117T2 (de) 2004-08-26
IL119744A (en) 2003-01-12
BR9605777A (pt) 1998-08-25
MX9606009A (es) 1997-08-30
SK154296A3 (en) 1997-08-06
HU9603329D0 (en) 1997-01-28
CZ353296A3 (en) 1997-08-13
ATE263565T1 (de) 2004-04-15
JPH09169650A (ja) 1997-06-30
ES2215187T3 (es) 2004-10-01
ZA969923B (en) 1998-05-26

Similar Documents

Publication Publication Date Title
BR9508247A (pt) Derivados de 2-arilciclopentano-2,3-dionas
DK0823889T3 (da) 1,3-propandiolderivater som bioaktive forbindelser
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
FI932527L (fi) Anvaendning av polypropylenglykol saosom tillsatsaemne, som reducerar krympningens storlek i dispersionspulversammansaettningar avsedda foer byggmaterialer
NO984385D0 (no) Substituerte 1,2,3,4-tetrahydronaftalenderivater
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
AU9746698A (en) 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
FI941307A0 (fi) Tjulvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
AU4361696A (en) New uses of indolo-{2,3b}-quinoxalines
NO965165L (no) Anvendelse av 8,9-dehydroestron som en antioksydant
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
FI964278A7 (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdann aisten valmistamiseksi
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
ZA974679B (en) New use of derivatives of cystine.
FI944023A0 (fi) Foerfarande foer identifiering av avvikelser i en yta som granskas
AU5341098A (en) Fulgimide compounds, use of them, and compositions containing the same
FI954341A0 (fi) Foerfarande foer att ordna som skall presenteras pao en bildskaerm av en dator
DK0770603T3 (da) Alkynylphenylaminosulfonylurinstoffer som herbicider
FI954263A0 (fi) Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar
FI943675A0 (fi) Foerfarande foer framstaellning av skal som behoevs vid skalformsgjutning
FI944993A0 (fi) Foerfarande foer framstaellning av en betongyta som liknar natursten
FI20040505A7 (fi) Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi